Mabion
  • Company
    • About us
      • History
      • Leaderships
      • Team
      • EU grants
      • Requests for Proposal
      • Sustainability – ESG
      • Bussines strategy
      • Quality policy
      • Virtual Tour
    • Investors
      • Corporate documents
      • Shareholders and shares
      • Periodic reports
      • Current reports
      • Sustainability reports
      • Corporate governance at Mabion
      • Financial data
      • For Investors
      • Calendar
  • Resources
    • Science Hub
    • Press releases
    • News
    • Events
    • Media kit
  • Services
    • Process Development
    • Analytics 
    • Drug Substance Manufacturing
  • Contact
    • Contact form
    • Contact for investors
    • Contact for media
    • Careers
  • Science News
  • Resources

Manufacturing

optimal CHO cell culture upstream process

Metabolite and nutrient analysis as crucial components for optimal CHO cell culture upstream process

Cell culture, Drug substance, Manufacturing
Mycoplasma Contamination Risks in Biomanufacturing

Mycoplasma contamination in biopharmaceutical manufacturing

Biologics, Cell culture, Contamination, Manufacturing
Glycosylation's Impact on Antibody Effector Functions

Impact of glycosylation on the effector functions of monoclonal antibodies: a case study of rituximab

Bioanalytics, Biologics, Drug substance, Manufacturing
Previous 1 … 3 4

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • CDMO
    • Media kit
    • Press releases
    • Events

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. HTML Sitemap

    Powered by

    Veneo